Md Wahiduzzaman
Nagakute, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Editorial: Research in obesity, type 2 diabetes, and metabolic syndrome: cellular pathways and therapeutic innovations.
Journal: Frontiers in cell and developmental biology
Published: April 08, 2026
Nintedanib inhibits the VEGFR-ERK signaling pathway in human KRAS-mutated cancer cells.
Journal: Cell death & disease
Published: January 20, 2026
Targeting fatty acid synthase suppresses tumor development in NF2/CDKN2A-deficient pleural mesothelioma.
Journal: Cell death & disease
Published: February 11, 2025
Adiponectin: A Promising Target for the Treatment of Diabetes and Its Complications.
Journal: Life (Basel, Switzerland)
Published: October 10, 2023
ARK5 enhances cell survival associated with mitochondrial morphological dynamics from fusion to fission in human multiple myeloma cells.
Journal: Cell death discovery
Published: June 22, 2023
CAMK2D: a novel molecular target for BAP1-deficient malignant mesothelioma.
Journal: Cell death discovery
Published: December 05, 2022
Experimental strategies to achieve efficient targeted knock-in via tandem paired nicking.
Journal: Scientific reports
Published: May 19, 2021
CD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemia.
Journal: Cell death discovery
Published: October 02, 2020
Novel Interleukin-6 Inducible Gene PDZ-Binding Kinase Promotes Tumor Growth of Multiple Myeloma Cells.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: July 30, 2020
Discovery of novel molecular characteristics and cellular biological properties in ameloblastoma.
Journal: Cancer medicine
Published: October 30, 2019
Last Updated: 09/26/2026